
How AI Vocal Biomarkers Are Turning Speech Into a Vital Sign
AI-driven vocal biomarkers are emerging as a rapid, non‑invasive method to screen for a wide range of neurological and mental‑health conditions. Research validates their ability to identify mild cognitive impairment, Alzheimer’s, depression, anxiety, Parkinson’s, multiple sclerosis and Huntington’s disease from a brief 40‑second voice sample. Companies such as Canary Speech are partnering with major health systems and tech firms to integrate this technology into wearable devices and telehealth platforms. The approach promises scalable, remote screening that can trigger early interventions and reduce downstream medical costs.
Sudan Clinics Face Stock-Out in Weeks Due to Middle East War, NGO Says
Save the Children warns that essential medicines for Sudan’s government‑run clinics could be exhausted within two weeks because the Middle East war has blocked key shipping routes. About $600,000 of drugs are stranded in Dubai, and rising freight costs—up 25‑30%...

Turquoise Health Secures $40M for AI-Powered Healthcare Pricing Platform
Turquoise Health announced a $40 million Series C round, led by Oak HC/FT with participation from a16z, Adams Street Partners and Yosemite. The funding will accelerate its transition from a pricing data vendor to an AI‑driven workflow and transaction operating system that...
In MS Diagnosis, the Case for Κ-FLC Index
An international expert panel has recommended that the intrathecal kappa free light chain (κ‑FLC) index be added to the next revision of multiple sclerosis (MS) diagnostic criteria as a quantitative, cost‑effective alternative to oligoclonal bands (OCBs). κ‑FLC can be measured...

Get a Fuller Picture with Fitbit's Personal Health Coach
Fitbit unveiled the next phase of its AI‑driven personal health coach, boosting sleep‑stage accuracy by 15% and introducing a more granular Sleep Score that tracks latency and interruptions. The company highlighted new research published in *Nature* that predicts insulin resistance...

How Google Is Using AI to Improve Health for Everyone
Google announced a suite of AI‑driven health initiatives, beginning with a partnership in Arkansas to pilot a rural‑health transformation model. The company is allocating $10 million through Google.org to reimagine clinician education alongside leading medical societies. AI enhancements are also rolling...
NQO1‐Responsive Prodrug for in Cellulo Release of Cytochalasin B as Cancer Cell‐Targeted Migrastatic (Small 16/2026)
Researchers introduced BQTML‑CB, an NQO1‑responsive prodrug that releases cytochalasin B inside tumor cells, disrupting actin filaments and halting migration and proliferation. The design exploits the enzyme NQO1, overexpressed in many aggressive cancers, to achieve tumor‑selective activation while sparing NQO1‑deficient cells and...
Suckerin Colloids and Hydrogels With Low Immunogenicity as Resorbable and Hemostatic Tissue Adhesives for Wound Healing
Researchers have engineered recombinant suckerin‑12 colloids and hydrogels that act as wet‑resistant tissue adhesives. The materials exhibit stronger adhesion than traditional mussel‑derived proteins and outperform fibrin glue in hemostasis, cell proliferation, and wound closure in animal models. Low cytotoxicity, minimal...
AI in Healthcare Forum
The AI in Healthcare Forum convened clinicians, executives, and technologists in Boston to showcase real‑world AI applications across care delivery, operations, and governance. Sessions covered policy frameworks, data challenges, scaling strategies, and emerging clinical AI tools, featuring leaders from Sutter...
Third FDA Rejection for Aldeyra’s Dry Eye Disease Drug Sends Shares Plummeting
The FDA issued a third complete response letter rejecting Aldeyra Therapeutics' lead dry‑eye candidate, reproxalap, citing a lack of substantial evidence and inconsistent efficacy data. The agency noted the drug failed to demonstrate clear benefit in well‑controlled studies, though no...

CT-Like Chest Imaging at the Bedside Sans Radiation?
Engineers at the University of Hong Kong have unveiled SonoMeta, an AI‑assisted ultrasound lens built from metamaterials that can image heart and lung structures up to 10 cm behind the rib cage with CT‑like resolution. Validation shows spatial resolution under 500 µm...
Doctor Calls for Meningitis B Catch-Up Jabs for All UK Teens Born Before 2015
Dr Niamh Lynch is urging the NHS to launch a catch‑up MenB vaccination programme for all UK teenagers born before September 2015, after a deadly meningitis B outbreak in Kent claimed two lives and left eleven seriously ill. The strain now...

Kenya’s Flood Response Shows the Promise — and Limits — of ‘One Health’
In 2024, severe flooding in Kenya’s Tana River County sparked a cholera outbreak that overwhelmed local health facilities. Authorities deployed a One Health strategy, integrating human, animal, and environmental agencies to coordinate surveillance, water treatment, and vaccination campaigns. The approach...

Can Bristol Myers Squibb’s Pipeline Strategy Offset a Major Patent Cliff?
Bristol Myers Squibb faces a major patent cliff as flagship drugs like Revlimid, Pomalyst, Opdivo and Eliquis lose exclusivity, threatening its revenue base. To counteract the decline, the company is reshaping its pipeline through internal R&D and high‑profile acquisitions, emphasizing...
Moving Beyond Individual-Level Factors: Evidence-Based Strategies to Advance Structural Competency in Sports and Exercise Medicine
The editorial calls for sports and exercise medicine to shift focus from individual behavior to structural determinants of musculoskeletal health. It highlights persistent racial and ethnic disparities in physical activity and rehabilitation outcomes, rooted in housing policies, economic inequities, and...
Effectiveness of Cryotherapy on Pain Intensity, Range of Motion, Swelling and Function in the Postoperative Care of Musculoskeletal Disorders: A...
A systematic review and meta‑analysis of 28 randomized trials involving roughly 3,000 postoperative patients evaluated cryotherapy’s impact on pain, range of motion, swelling, and function after musculoskeletal surgery. The analysis showed statistically significant pain reductions (MD −0.77 to −0.41) and modest improvements...

The “Third Way” For Digital Health Engagement
Kris Narayan argues that today’s health‑tech landscape is split between EMR giants that protect clinical data within the office and consumer‑focused AI tools that demand medical expertise to use. Both approaches fail to engage patients during the daily "micro‑moments" after...

So, What Can You Use Your HSA/FSA Money For?
Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) let employees spend pre‑tax dollars on qualified medical costs, and many retailers now classify beauty and wellness items as eligible. HSA balances typically roll over year‑over‑year, while most FSAs expire unless...

Are Pig Organs the Future of Transplantation?
The United States faces a transplant shortage of over 100,000 patients, prompting research into xenotransplantation using genetically engineered pig organs. Recent cases—David Bennett’s pig heart in 2022, Lawrence Faucette’s in 2023, and Tim Andrews’ pig kidney in 2025—demonstrate feasibility, with...

Lilly Gets Lone Sell From HSBC Ahead of Deeper Weight Loss Drug Price Cuts
Eli Lilly shares fell after HSBC issued a lone sell rating, the second bearish call in a year, citing overinflated expectations for its weight‑loss drugs. Analysts led by Rajesh Kumar downgraded the stock to a sell‑equivalent rating and lowered the...

NVIDIA and Persistent Systems Partner to Bring ‘Agentic AI’ to Drug Discovery
Persistent Systems has partnered with NVIDIA to bring Agentic AI to the healthcare and life‑sciences sector, focusing on computational drug discovery. Leveraging NVIDIA’s full AI stack—including AI Enterprise, BioNeMo, the NeMo Agent Toolkit, and NIM microservices—Persistent built GenMolVS, a generative...

CMS Implements Enhanced Oversight for MAC MBI Lookup Tools
The Centers for Medicare & Medicaid Services (CMS) is tightening oversight of Medicare Administrative Contractor (MAC) MBI lookup tools to combat hospice fraud. The agency will now match MBI searches against submitted claims using National Provider Identifiers (NPIs) and may...
The 2026 Convergence: Big Tech, Agentic AI and the Restructuring of the Global HealthTech Ecosystem
In early 2026 the world’s leading technology firms launched agentic health AI platforms, shifting from passive information retrieval to proactive health stewardship. Microsoft introduced Copilot Health, aggregating data from over 50,000 U.S. hospitals and dozens of wearable ecosystems, while Amazon...

Azara Healthcare Joins MEDITECH Alliance to Integrate Population Health Platform
Azara Healthcare has entered the MEDITECH Alliance, linking its Azara DRVS population‑health platform with the MEDITECH Expanse electronic health record. The integration is aimed at community and critical‑access hospitals, offering an out‑of‑the‑box data aggregation layer that combines clinical records, claims...

EMA Marketing Authorization of New Drugs in February 2026
In February 2026 the European Commission and the CHMP granted marketing authorisations and positive opinions for a slate of innovative therapies spanning COVID‑19, oncology, cardiology, immunology and rare diseases. Notable approvals include Moderna’s mNEXSPIKE COVID‑19 vaccine, Hansoh’s Aumseqa for EGFR‑mutated...

Center for Radiology Education to Provide Medical Imaging Scholarships at John Patrick University
The Center for Radiology Education (CRE) announced a nationwide scholarship initiative for students enrolling in medical imaging programs at John Patrick University (JPU). Up to 5,000 scholarships worth as much as $10,000 each will be awarded in 2026, targeting a...
Despite Pressures, Healthcare Construction Spending to Increase
Construction spending for hospitals and clinics is set to hit $30.7 billion in 2026, an 11.6% jump from 2025 and the highest level since the 2024 record. ConstructConnect projects a 7% compounded annual growth rate, reaching $38.8 billion by 2030, driven by...
For Newer Sepsis Diagnostics, What the Studies Show
Newer sepsis diagnostics such as monocyte distribution width (MDW), Intellisep, and MeMed BV are showing promise in early clinical studies but each has distinct limitations. MDW, available on the Beckman Coulter CBC platform, improves sepsis detection when combined with white‑blood‑cell...

Transcarent Partners with Bluespine to Launch Payment Integrity Category for Self-Insured Employers
Transcarent has added a new “Payment Integrity” category to its Experience Store through a partnership with AI‑driven health‑tech firm Bluespine. The service targets the $300 billion annual loss from fraud, waste and abuse in U.S. healthcare by analyzing every medical and...
Turner Goes Vertical on $900M Pennsylvania Hospital Expansion
Turner Construction has begun vertical construction on an 11‑story, 600,000‑square‑foot expansion at Geisinger Wyoming Valley Medical Center, a $900 million project that will raise bed capacity from 356 to 500 and increase operating rooms to 18. The tower will contain more...

One Decision-Maker per Team: Inside Pfizer’s Cross-Functional Operating Model
Pfizer accelerated its COVID‑19 vaccine development by overhauling its traditional operating model. The company compressed four‑level approval chains and shifted decision authority from committees to a single leader per cross‑functional team. This one‑decision‑maker approach enabled rapid iteration and alignment across...

Pfizer Reports P-II (FOURLIGHT-1) Trial Data on Atirmociclib Combination for 2L Metastatic Breast Cancer
Pfizer disclosed topline Phase II (FOURLIGHT‑1) data showing that atirmociclib combined with fulvestrant outperformed fulvestrant alone or everolimus + exemestane in 264 HR+, HER2‑negative metastatic breast cancer patients previously treated with CDK 4/6 inhibitors. The trial met its primary endpoint, delivering a statistically significant...

Cancer Vaccines Could Transform Treatment and Prevention – but Misinformation About mRNA Vaccines Threatens Their Potential
Scientists are accelerating development of mRNA cancer vaccines, with more than 120 clinical trials targeting melanoma, brain, breast, lung and prostate tumors. Early studies, such as personalized vaccines for glioblastoma, demonstrate rapid immune activation and improved survival. Simultaneously, a false...

Magic Mushroom-Infused Products Appear in Colorado Gas Stations – What Public Health Officials Want Consumers to Know
Colorado health officials have seized and destroyed PolkaDot‑branded chocolate bars, gummies and shots sold in gas stations that were marketed as mushroom blends but contained psilocybin, psilocin and synthetic tryptamines. The products bypassed FDA oversight by exploiting the dietary supplement...
Health Insurance Priority for Government, to Cover All by 2033: Nirmala Sitharaman
Finance Minister Nirmala Sitharaman announced that India aims for universal health‑insurance coverage by 2033, building on a market that insured 58 crore lives in FY 2024‑25. The sector’s premium volume hit Rs 1,17,505 crore, with public, private and standalone insurers contributing roughly equally. Recent regulatory...

China’s Control Over US Drug Supply Alarms Lawmakers
U.S. lawmakers warned that China dominates the supply chain for essential hospital and outpatient medicines, especially generic drugs that fill 90% of prescriptions. Witnesses at a Senate Aging Committee hearing highlighted that China controls roughly 90% of key starting materials...

Scientists Finally Reveal How This Alzheimer’s Drug Really Works
Scientists from VIB and KU Leuven have identified the mechanism by which lecanemab (Leqembi) clears amyloid plaques in Alzheimer’s disease. Their study shows that the antibody’s Fc fragment engages microglia, reprogramming them to phagocytose and degrade plaques. Removing the Fc...

Devex Newswire: US Congress Defies Trump with $600M for Family Planning
U.S. Congress approved a $600 million carve‑out for family planning and reproductive health within a broader $50 billion foreign‑affairs package, directly contradicting President Trump’s anti‑abortion agenda. The administration’s expanded Mexico City Policy and withdrawal from UN women agencies raise doubts about whether...

Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis commissioned Datos Insights to survey over 2,200 health‑plan executives, employer‑benefits leaders and insured consumers, revealing mounting financial pressure across the healthcare ecosystem. The study shows that 63% of employers view price transparency as a key cost‑management tool, while 68%...
Cooper University Health Care’s Curran Says Cross-Functional Collaboration Was the Key to Securing More Than 10,000 Edge Devices
Cooper University Health Care completed an 18‑month program that lifted device visibility from 25 percent to 100 percent across more than 10,000 IoT and medical devices. The effort relied on passive network‑monitoring tools, rigorous network segmentation, and a new security‑by‑procurement framework. A...
NYU Langone Health’s O’Brien & Major Explain Keys to Effective Nursing/AI Partnership
NYU Langone Health has built a structured partnership between nursing informatics and data science that fuels AI tool development and adoption. Since 2019, the collaboration has produced decision‑support models, a pressure‑injury prevention system, and a fall‑prediction tool, all vetted through...
Northwestern Medicine’s Sama Says AI Optimization Requires a New Data Foundation
During HIMSS 2026, Northwestern Medicine’s VP Danny Sama warned that health‑system AI initiatives are outpacing investment in core data infrastructure. He noted that roughly 80 percent of effort is spent on AI while the underlying data plumbing remains underfunded, exposing technical debt....
New York-Presbyterian’s Linsangan Says Live Simulations Expose What Tabletop Exercises Miss
New York‑Presbyterian launched live downtime simulations across its ten hospitals after a cyberattack at a peer institution highlighted systemic vulnerabilities. The exercises, run during peak daytime hours on real patient scenarios, revealed that many clinicians lacked paper‑charting experience, struggled with medication...

Is GLP-1 Itch Something to Be Concerned About?
Recent reports and media coverage highlight itchy skin as a newly recognized side effect of GLP‑1 agonists such as semaglutide (Ozempic, Wegovy). Dermatology and weight‑loss specialists say the symptom is uncommon but has been observed, particularly among patients experiencing rapid...

AstraZeneca Secures the EC Approval of Imfinzi as a Perioperative Therapy for G/GEJ Cancers
The European Commission has granted approval for AstraZeneca’s Imfinzi (durvalumab) combined with FLOT chemotherapy as a perioperative treatment for resectable, early‑stage and locally advanced gastric and gastro‑esophageal junction (G/GEJ) cancers. The decision is based on the Phase III MATTERHORN trial, which...

GEN Secures BEBO Foundation Approval for Phase II PD Trial
GEN Pharmaceuticals received BEBO Foundation ethical approval to launch a Phase II proof‑of‑concept trial of its mitochondrial‑targeting drug SUL‑238 in Parkinson’s disease. The single‑centre, randomised, double‑blind, placebo‑controlled study, named SHEPHERD, will begin patient enrolment in Groningen in April 2026. Over a 28‑day...
What the Evolving Microbial Nomenclature Means for the Clinical Microbiology Lab
Rapid advances in whole‑genome sequencing are prompting frequent revisions to microbial taxonomy and nomenclature, creating operational challenges for clinical microbiology labs. While some updates—such as recognizing Staphylococcus pseudintermedius—enhance antimicrobial‑resistance insight and enable species‑specific susceptibility breakpoints, other changes driven mainly by...
I'm Concerned About My Blood Pressure. Can I Check It at Home?
Hypertension affects about 31 % of adults worldwide, and a single office reading often fails to capture true blood‑pressure trends due to stress and white‑coat effects. The American College of Cardiology now recommends home monitoring to supplement annual screenings, providing multiple...
I Had to Man up and Get a Mammogram
A man with a BRCA1 mutation underwent his first mammogram, discovering that the procedure is virtually identical for men and women. The article highlights the rarity of male breast cancer—about 1 in 726 men—but notes that genetic risk and family...

Maine Could Determine Abortion Rights for the Nation. Why Aren’t Reproductive Rights Groups Acting Accordingly?
Maine’s 2026 Senate race has become a bellwether for the Democratic quest to regain a Senate majority, with Governor Janet Mills positioning herself as the party’s most viable challenger to incumbent Susan Collins. Reproductive‑rights groups such as EMILY’s List and...